Detalhe da pesquisa
1.
Neurological adverse events of immune checkpoint blockade: from pathophysiology to treatment.
Curr Opin Neurol
; 35(6): 814-822, 2022 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36226705
2.
Synthetic Melanin Acts as Efficient Peptide Carrier in Cancer Vaccine Strategy.
Int J Mol Sci
; 23(23)2022 Nov 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-36499300
3.
The adjuvant effect of melanin is superior to incomplete Freund's adjuvant in subunit/peptide vaccines in mice.
Cancer Immunol Immunother
; 69(12): 2501-2512, 2020 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-32561966
4.
VEGFA SNP rs2010963 is associated with vascular toxicity in recurrent glioblastomas and longer response to bevacizumab.
J Neurooncol
; 121(3): 499-504, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25488073
5.
REVOLUMAB: A phase II trial of nivolumab in recurrent IDH mutant high-grade gliomas.
Eur J Cancer
; 202: 114034, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38537315
6.
Assessing cognitive function in patients treated with immune checkpoint inhibitors: A feasibility study.
Psychooncology
; 27(7): 1861-1864, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29624771
7.
Mismatch Repair Deficiency and Lynch Syndrome Among Adult Patients With Glioma.
JCO Precis Oncol
; 7: e2200525, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37262394
8.
Long-term Neurologic Safety in Patients With B-Cell Lymphoma Treated With Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy.
Neurology
; 99(12): 511-515, 2022 Sep 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-35851255
9.
Applications of Melanin and Melanin-Like Nanoparticles in Cancer Therapy: A Review of Recent Advances.
Cancers (Basel)
; 13(6)2021 Mar 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-33806772
10.
Evaluation of mid-term (6-12 months) neurotoxicity in B-cell lymphoma patients treated with CAR T cells: a prospective cohort study.
Neuro Oncol
; 23(9): 1569-1575, 2021 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33822183
11.
Eprenetapopt Plus Azacitidine in TP53-Mutated Myelodysplastic Syndromes and Acute Myeloid Leukemia: A Phase II Study by the Groupe Francophone des Myélodysplasies (GFM).
J Clin Oncol
; 39(14): 1575-1583, 2021 05 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33600210
12.
Cancer Vaccines: Adjuvant Potency, Importance of Age, Lifestyle, and Treatments.
Front Immunol
; 11: 615240, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33679703
13.
Immune Escape in Glioblastoma Multiforme and the Adaptation of Immunotherapies for Treatment.
Front Immunol
; 11: 582106, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33178210
14.
Impact of New Systemic Treatment and Radiotherapy in Melanoma Patients with Leptomeningeal Metastases.
Cancers (Basel)
; 12(9)2020 Sep 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-32947841
15.
Reintroduction of immune-checkpoint inhibitors after immune-related meningitis: a case series of melanoma patients.
J Immunother Cancer
; 8(2)2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32747471
16.
Management of immune-related adverse events resulting from immune checkpoint blockade.
Expert Rev Anticancer Ther
; 19(3): 209-222, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30572735
17.
Survival gain in glioblastoma patients treated with dendritic cell immunotherapy is associated with increased NK but not CD8+ T cell activation in the presence of adjuvant temozolomide.
Oncoimmunology
; 7(4): e1412901, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29632727
18.
Glioblastomas: what's new? / Glioblastomes : quoi de neuf ?
Rev Prat
; 65(9): 1199-1201, 2015 11.
Artigo
em Francês
| MEDLINE | ID: mdl-30512510
19.
Cochleovestibular toxicity induced by immune checkpoint inhibition: a case series.
Eur J Cancer
; 117: 116-118, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31279302